Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial
- Citation:
- J Clin Oncol vol 26 (suppl) abstr 13525
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 316
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- S. G. Holtan N. R. Foster C. E. Erlichman M. Aubry M. M. Ames S. Safgren P. D. Steen R. F. Morton D. Graham M. P. Goetz
- Networks:
- Study
- NCCTG-N004E
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: